Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester

Ähnliche Einträge

• Correction to “Cohort Study of Pregnancy Outcomes After Exposure to Fexofenadine or Olopatadine in the First Trimester”
  Veröffentlicht: (2026)
• Clarithromycin Use in the First Trimester Is Not Associated With Fetal Abnormalities
  von: Tomo Suzuki, et al.
  Veröffentlicht: (2026)
• Risk of major birth defects after first‐trimester exposure to carbocisteine and ambroxol: A multicenter prospective cohort study using counseling data for drug safety during pregnancy
  von: Mariko Usuda, et al.
  Veröffentlicht: (2024)
• A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan
  von: Mariko Honma, et al.
  Veröffentlicht: (2024)
• Compound heterozygous ZNF335 variants in a patient with microcephaly, refractory epilepsy, and severe developmental delay: A case report and literature review
  von: Kaori Yamoto, et al.
  Veröffentlicht: (2025)